Home - Products - Chromatin/Epigenetic - COX - Caffeic Acid 3-Methyl Phenethyl Ester

Caffeic Acid 3-Methyl Phenethyl Ester

CAS No. 71835-85-3

Caffeic Acid 3-Methyl Phenethyl Ester( Phenethyl ferulate )

Catalog No. M24728 CAS No. 71835-85-3

Caffeic Acid 3-Methyl Phenethyl Ester has chemopreventive properties against chemically induced colon carcinogenesis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 117 In Stock
5MG 122 In Stock
10MG 202 In Stock
25MG 340 In Stock
50MG 491 In Stock
100MG 710 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Caffeic Acid 3-Methyl Phenethyl Ester
  • Note
    Research use only, not for human use.
  • Brief Description
    Caffeic Acid 3-Methyl Phenethyl Ester has chemopreventive properties against chemically induced colon carcinogenesis.
  • Description
    Caffeic Acid 3-Methyl Phenethyl Ester has chemopreventive properties against chemically induced colon carcinogenesis. It enhances apoptosis in azoxymethane induced colon tumors. It shows inhibitory activity against cyclooxygenase (COX) and 5-lipoxygenase (5-LOX) with IC50 values of 4.35 μM and 5.75 μM, respectively.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Phenethyl ferulate
  • Pathway
    Chromatin/Epigenetic
  • Target
    COX
  • Recptor
    5-LOX|COX
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    71835-85-3
  • Formula Weight
    298.34
  • Molecular Formula
    C18H18O4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    O=C(OCCC1=CC=CC=C1)C=CC2=CC(OC)=C(O)C=C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Mofezolac

    Mofezolac (formerly known as Disopain or N-22) is a highly selective COX-1 (cyclooxygenase-1) inhibitor with COXs selectivity index > 6000.

  • Agnuside

    Agnuside inhibits COX-2 (IC50: 0.026 mg/ml) but exhibits less than 10% inhibition of COX-1 at this concentration. It also inhibits 46.3 66.8 and 82.1% of P-glycoprotein (P-gp) ATPase activity at concentrations of 5 25 and 100 μM respectively.

  • Ampiroxicam

    The prodrug of piroxicam that is a nonsteroidal anti-inflammatory drug (NSAID).